Literature DB >> 9357925

Medium chain 3-ketoacyl-coenzyme A thiolase deficiency: a new disorder of mitochondrial fatty acid beta-oxidation.

T Kamijo1, Y Indo, M Souri, T Aoyama, T Hara, S Yamamoto, S Ushikubo, P Rinaldo, I Matsuda, A Komiyama, T Hashimoto.   

Abstract

A Japanese male neonate died at 13 d of age after presenting at 2 d of age with vomiting, dehydration, metabolic acidosis, liver dysfunction, and terminal rhabdomyolysis with myoglobinuria. Multiple urine organic acid analyses consistently revealed a markedly elevated excretion of lactic acid, 3-hydroxybutyric acid, and saturated and unsaturated C6-C16 dicarboxylic acids, with predominant C12-C16 species. Oxidation of [1-14C]octanoic acid in cultured skin fibroblasts was significantly reduced (0.59 nmol/h/mg of protein; controls, 1.93 +/- 0.65), [1-14C]palmitic acid oxidation was 1.11 nmol/h/mg of protein (controls, 1.63 +/- 0.41). A systematic study of the catalytic activities of nine enzymes of the beta-oxidation cycle using the respective optimal substrate revealed a deficiency of a single enzyme not previously associated with a metabolic disorder, medium chain 3-ketoacyl-CoA thiolase (patient, 3.9 nmol/min/mg protein; controls (n = 6), 10.2 +/- 2.3). Immunoprecipitation with antibodies raised against medium chain 3-ketoacyl-CoA thiolase revealed a 60% decrease compared with controls.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357925     DOI: 10.1203/00006450-199711000-00002

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

Review 1.  Disorders of mitochondrial fatty acyl-CoA beta-oxidation.

Authors:  R J Wanders; P Vreken; M E den Boer; F A Wijburg; A H van Gennip; L IJlst
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Quantitative measurement of total and free 3-hydroxy fatty acids in serum or plasma samples: short-chain 3-hydroxy fatty acids are not esterified.

Authors:  P M Jones; A B Burlina; M J Bennett
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

3.  The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.

Authors:  Ronald J A Wanders; Jos P N Ruiter; Lodewijk IJLst; Hans R Waterham; Sander M Houten
Journal:  J Inherit Metab Dis       Date:  2010-05-20       Impact factor: 4.982

4.  Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase.

Authors:  Margarida F B Silva; Jos P N Ruiter; Henk Overmars; Albert H Bootsma; Albert H van Gennip; Cornelis Jakobs; Marinus Duran; Isabel Tavares de Almeida; Ronald J A Wanders
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

5.  Mitochondrial fatty acid oxidation defects--remaining challenges.

Authors:  Niels Gregersen; Brage S Andresen; Christina B Pedersen; Rikke K J Olsen; Thomas J Corydon; Peter Bross
Journal:  J Inherit Metab Dis       Date:  2008-10-07       Impact factor: 4.982

6.  Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Marcus J Miller; Kristina Cusmano-Ozog; Devin Oglesbee; Sarah Young
Journal:  Genet Med       Date:  2020-10-19       Impact factor: 8.822

7.  Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.

Authors:  David Grünig; Urs Duthaler; Stephan Krähenbühl
Journal:  Front Pharmacol       Date:  2018-04-23       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.